Evidence map›Paper›PMID 41805992›Full record

ReviewPediatric radiology2026

Neonatal primary pulmonary neoplasms, clinical, imaging, and differential diagnosis.

Beverley Newman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Beverley NewmanDepartment of Radiology, Stanford University, Stanford Childrens Hospital, 725 Welch Rd, Palo Alto, CA, 94304, USA. bevn@stanford.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most prenatal/neonatal pulmonary masses are non-neoplastic congenital bronchopulmonary malformations. However, both benign and malignant primary pulmonary neoplasms do occur. While rare, these neoplasms can be difficult to differentiate from one another, as well as from other congenital and some acquired pulmonary lesions, including occasional mediastinal and chest wall masses. Misdiagnosis or delayed identification of a pulmonary neoplasm can result in incorrect or delayed management decisions and therapy, adversely affecting outcomes. Atypical timing of presentation, rapid growth, and unusual or heterogeneous imaging appearance should raise suspicion for a neoplastic lesion. There are some diagnostic and ultrasound, computed tomography, and magnetic resonance imaging features that help to differentiate these lesions, along with several useful genetic or biological identifying markers. This review will discuss and illustrate the clinical and imaging features of neonatal pulmonary neoplasms, as well as some of the conditions that are differential considerations.

Indexed as

Diagnostic ImagingLung NeoplasmsDiagnosis, DifferentialHumansInfant, NewbornComputed tomographyInfantInfant, newbornLung neoplasmsMagnetic resonance imagingUltrasonography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.